Payment overview · 2025
General Payments
$20.22
1 reported records · 1 companies
Healthcare provider profile · identity verified
James A Humphrey, D.O.
Allopathic & Osteopathic Physicians|Family Medicine · LEECHBURG, PA · NPI 1992816615
Verified facts
What the public records show
CMS Open Payments records show James A Humphrey, D.O. received $20.22 in general payments during 2025 across 1 reported records.
Bayer Healthcare Pharmaceuticals Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $20.22 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Education | $20.22 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Kerendia Normalized: kerendia |
Drug | Bayer Healthcare Pharmaceuticals Inc. | $20.22 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 564 | 197 |
| Levothyroxine Sodium | Levothyroxine Sodium | 513 | 117 |
| Amlodipine Besylate | Amlodipine Besylate | 511 | 145 |
| Lisinopril | Lisinopril | 330 | 104 |
| Gabapentin | Gabapentin | 327 | 77 |
| Pantoprazole Sodium | Pantoprazole Sodium | 315 | 92 |
| Omeprazole | Omeprazole | 305 | 84 |
| Metformin Hcl | Metformin Hcl | 291 | 89 |
| Metoprolol Tartrate | Metoprolol Tartrate | 231 | 56 |
| Trazodone Hcl | Trazodone Hcl | 222 | 56 |
| Meloxicam | Meloxicam | 214 | 59 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 210 | 40 |
| Metoprolol Succinate | Metoprolol Succinate | 208 | 49 |
| Losartan Potassium | Losartan Potassium | 205 | 67 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 201 | 48 |
| Tamsulosin Hcl | Tamsulosin Hcl | 195 | 58 |
| Furosemide | Furosemide | 191 | 54 |
| Jardiance | Empagliflozin | 190 | 44 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 181 | 67 |
| Eliquis | Apixaban | 174 | 34 |
| Escitalopram Oxalate | Escitalopram Oxalate | 164 | 46 |
| Hydrochlorothiazide | Hydrochlorothiazide | 146 | 47 |
| Clonazepam | Clonazepam | 143 | 46 |
| Sertraline Hcl | Sertraline Hcl | 140 | 36 |
| Simvastatin | Simvastatin | 140 | 46 |
| Duloxetine Hcl | Duloxetine Hcl | 119 | 30 |
| Zolpidem Tartrate | Zolpidem Tartrate | 118 | 27 |
| Potassium Chloride | Potassium Chloride | 114 | 29 |
| Fluticasone Propionate | Fluticasone Propionate | 109 | 39 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 106 | 27 |
| Clopidogrel | Clopidogrel Bisulfate | 105 | 29 |
| Allopurinol | Allopurinol | 103 | 31 |
| Alendronate Sodium | Alendronate Sodium | 100 | 23 |
| Alprazolam | Alprazolam | 94 | 35 |
| Celecoxib | Celecoxib | 92 | 23 |
| Ozempic | Semaglutide | 90 | 25 |
| Bupropion Xl | Bupropion Hcl | 89 | 24 |
| Carvedilol | Carvedilol | 86 | 22 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 81 | 16 |
| Valsartan | Valsartan | 78 | 26 |
| Metformin Hcl Er | Metformin Hcl | 77 | 28 |
| Spironolactone | Spironolactone | 75 | 18 |
| Buspirone Hcl | Buspirone Hcl | 74 | 16 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 73 | 26 |
| Lorazepam | Lorazepam | 72 | 19 |
| Citalopram Hbr | Citalopram Hydrobromide | 67 | 20 |
| Tramadol Hcl | Tramadol Hcl | 67 | 21 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 67 | 25 |
| Prednisone | Prednisone | 66 | 42 |
| Amoxicillin | Amoxicillin | 63 | 48 |
| Pregabalin | Pregabalin | 63 | 13 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 62 | 20 |
| Azithromycin | Azithromycin | 60 | 51 |
| Fenofibrate | Fenofibrate Nanocrystallized | 56 | 11 |
| Bumetanide | Bumetanide | 55 | 13 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 54 | 15 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 54 | 12 |
| Topiramate | Topiramate | 54 | 11 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 52 | 11 |
| Famotidine | Famotidine | 52 | 18 |
| Farxiga | Dapagliflozin Propanediol | 52 | 14 |
| Xarelto | Rivaroxaban | 52 | suppressed |
| Aripiprazole | Aripiprazole | 51 | 11 |
| Fluoxetine Hcl | Fluoxetine Hcl | 50 | 11 |
| Montelukast Sodium | Montelukast Sodium | 48 | suppressed |
| Atenolol | Atenolol | 47 | 15 |
| Doxazosin Mesylate | Doxazosin Mesylate | 47 | suppressed |
| Mirtazapine | Mirtazapine | 46 | 17 |
| Ondansetron Hcl | Ondansetron Hcl | 45 | 14 |
| Donepezil Hcl | Donepezil Hcl | 44 | 11 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 44 | 19 |
| Trulicity | Dulaglutide | 44 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 43 | 31 |
| Ezetimibe | Ezetimibe | 39 | 12 |
| Ibuprofen | Ibuprofen | 39 | 14 |
| Glimepiride | Glimepiride | 38 | 12 |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 38 | suppressed |
| Fenofibrate | Fenofibrate | 37 | 11 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 36 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 35 | 11 |
| Quetiapine Fumarate | Quetiapine Fumarate | 33 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 32 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 31 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 31 | 13 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 29 | suppressed |
| Finasteride | Finasteride | 29 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 28 | suppressed |
| Myrbetriq | Mirabegron | 28 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 28 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 28 | suppressed |
| Baclofen | Baclofen | 27 | suppressed |
| Glipizide Er | Glipizide | 27 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 26 | 22 |
| Breo Ellipta | Fluticasone/Vilanterol | 26 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 26 | 23 |
| Levetiracetam | Levetiracetam | 26 | suppressed |
| Mounjaro | Tirzepatide | 26 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 25 | suppressed |
| Entresto | Sacubitril/Valsartan | 25 | suppressed |
| Glipizide | Glipizide | 25 | suppressed |
| Irbesartan | Irbesartan | 25 | suppressed |
| Naproxen | Naproxen | 25 | suppressed |
| Januvia | Sitagliptin Phosphate | 23 | suppressed |
| Lamotrigine | Lamotrigine | 23 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 23 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 23 | suppressed |
| Linzess | Linaclotide | 22 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 22 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 22 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 21 | suppressed |
| Nabumetone | Nabumetone | 20 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 19 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 19 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 19 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 19 | suppressed |
| Gemfibrozil | Gemfibrozil | 19 | suppressed |
| Ketoconazole | Ketoconazole | 19 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 19 | suppressed |
| Dulera | Mometasone/Formoterol | 18 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 18 | suppressed |
| Synthroid | Levothyroxine Sodium | 18 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 17 | suppressed |
| Lansoprazole | Lansoprazole | 17 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 17 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 17 | suppressed |
| Sucralfate | Sucralfate | 17 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 17 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 17 | suppressed |
| Ibu | Ibuprofen | 16 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 16 | 14 |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 16 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 15 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 14 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 14 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 14 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 14 | suppressed |
| Nitroglycerin | Nitroglycerin | 14 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 14 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 14 | 14 |
| Valacyclovir | Valacyclovir Hcl | 14 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Cephalexin | Cephalexin | 13 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Methocarbamol | Methocarbamol | 13 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 13 | suppressed |
| Vraylar | Cariprazine Hcl | 13 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 12 | suppressed |
| Fluconazole | Fluconazole | 12 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 12 | suppressed |
| Lovastatin | Lovastatin | 12 | suppressed |
| Otezla | Apremilast | 12 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 12 | suppressed |
| Tradjenta | Linagliptin | 12 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 11 | 11 |
| Humalog Kwikpen U-100 | Insulin Lispro | 11 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 11 | suppressed |
| Methylprednisolone | Methylprednisolone | 11 | suppressed |
| Mirabegron Er | Mirabegron | 11 | suppressed |
| Novolog Flexpen | Insulin Aspart | 11 | suppressed |
| Nystatin | Nystatin | 11 | suppressed |
| Olanzapine | Olanzapine | 11 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 11 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 11 | suppressed |
| Vascepa | Icosapent Ethyl | 11 | suppressed |
| Verapamil Er | Verapamil Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $20.22 · 1 records | Bayer Healthcare Pharmaceuticals Inc. | Kerendia | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error